FindTrial
Sign In

Application and extension of the rapid and simple test kit of combined urinary sodium / creatinine / albumin in patients with essential hypertension in primary medical institutions

Application and extension of the rapid and simple test kit of combined urinary sodium / creatinine / albumin in patients with essential hypertension in primary medical institutions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027624
Enrollment
Unknown
Registered
2019-11-22
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Experimental group:Diagnose and treatment according to the requirement of the project, use measurement of urine sodium, creatinin and albumin
Control group:Conventional diagnose and treatment

Sponsors

People's Hospital, Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Essential hypertension, male or female; 2. Aged 18 to 75 years old; 3. Untreated or single medicine treatment, SBP equal or more than 140mmHg and/or DBP equal or more than 90mmHg; 4. Be able to answer questions clearly, agree to participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Taken two or more types of antihypertensive drugs; 2. Taking large dose diuretics; 3. Complicated with heart failure or chronic renal dysfunction; 4. Must taken other drugs that influent blood pressure; 5. Other conditions unsuitable to be enrolled in determined by doctors.

Design outcomes

Primary

MeasureTime frame
urine sodium;urine albumin creatinine ratio;—

Countries

China

Contacts

Public ContactWang Hongyi

People's Hospital Peking University

hyhl1996@163.com+86 13520342736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026